During the corresponding time, Bio Rad Laboratories Inc saw a revenue deteriorated by -0.05 % year on year, sequentially revenue grew by 10.08 %. While revenue at the Bio Rad Laboratories Inc 's corporate clients
Bio Rad Laboratories Inc's Comment on Sales, Marketing and Customers
Bio-Rad operates in two primary market segments: Life Science and Clinical Diagnostics. The Life Science segment supplies instruments, systems, reagents, and consumables for research and biopharmaceutical applications, including biopharmaceutical manufacturing, quality control, food safety testing, and science education. Its main customers are universities, medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, and food producers and testing laboratories. The Clinical Diagnostics segment provides diagnostic test systems, informatics solutions, test kits, and quality controls for clinical laboratories worldwide, focusing on in vitro diagnostics (IVD). Key customers include hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories. Bio-Rad operates globally, with approximately 40% of net sales generated in the United States and 60% internationally, primarily in Europe.
Bio Rad Laboratories Inc’s Comment on Sales, Marketing and Customers
Bio-Rad operates in two primary market segments: Life Science and Clinical Diagnostics. The Life Science segment supplies instruments, systems, reagents, and consumables for research and biopharmaceutical applications, including biopharmaceutical manufacturing, quality control, food safety testing, and science education. Its main customers are universities, medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, and food producers and testing laboratories. The Clinical Diagnostics segment provides diagnostic test systems, informatics solutions, test kits, and quality controls for clinical laboratories worldwide, focusing on in vitro diagnostics (IVD). Key customers include hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories. Bio-Rad operates globally, with approximately 40% of net sales generated in the United States and 60% internationally, primarily in Europe.
Sources:
Bio rad Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bio rad Laboratories Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bio rad Laboratories Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
74.55 %